NCT03589274 (WTPIII) is a NA clinical trial of I-FS-CBT in Alcohol Use Disorder, sponsored by Rutgers, The State University of New Jersey.

Who is sponsoring NCT03589274?

NCT03589274 is sponsored by Rutgers, The State University of New Jersey.

What drugs are being tested in NCT03589274?

Interventions in NCT03589274: I-FS-CBT, G-FS-CBT.

What condition does NCT03589274 study?

NCT03589274 studies Alcohol Use Disorder.

Is NCT03589274 still recruiting?

NCT03589274 is currently completed. Last updated 17 July 2018.

Last reviewed 2018-07-17 · How we verify

NCT03589274: WTPIII

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Testing CBT Models and Change Mechanisms for Alcohol Dependent Women

Completed NA Last updated 17 July 2018

What this trial tests

NA trial testing I-FS-CBT in Alcohol Use Disorder in 155 participants. Completed in 28 April 2014.

Timeline

1 June 2010

Primary endpoint
28 April 2014

28 April 2014

Quick facts

Lead sponsor	Rutgers, The State University of New Jersey
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	155
Start date	1 June 2010
Primary completion	28 April 2014
Estimated completion	28 April 2014

Drugs / interventions tested

I-FS-CBT
G-FS-CBT

Conditions studied

Alcohol Use Disorder — all drugs for Alcohol Use Disorder →

Sponsor

Rutgers, The State University of New Jersey

Who can join

18 and older, female only, with Alcohol Use Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study has 4 specific aims: (1) To modify our existing Individual Female Specific Cognitive Behavioral Therapy (I-FS-CBT) for Alcohol Use Disorder (AUD) approach to treat women with alcohol dependence in a group format, Group Female Specific Cognitive Behavioral Therapy (G-FS-CBT); (2) To test the relative efficacy of I-FS-CBT and G-FS-CBT; (3) To test hypothesized mechanisms of change in drinking that are common to both treatments, including (a) coping skills and enhanced self-efficacy for abstinence; (b) enhanced sense of autonomy; (c) alleviation of negative affect, and (d) increased social network support for abstinence, and (4) To assess the relative cost-effectiveness of the individual and group treatment.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Optimizing the length and reliability of measures of mechanisms of change to support measurement-based care in alcohol use disorder treatment.
Hallgren KA, Holzhauer CG, Epstein EE, McCrady BS, et al · · 2021 · cited 7× · PMID 34014690 · DOI 10.1037/ccp0000643

Verify or expand the search:

Other recruiting trials for Alcohol Use Disorder

Currently open trials in the same condition.

NCT06860607 — Environment and Alcohol: A Pilot Study · Phase 1 · recruiting
NCT07325266 — Human Laboratory Study of Apremilast for Alcohol Use Disorder · Phase 2 · recruiting
NCT07046819 — Tirzepatide in MetALD · Phase 2 · recruiting
NCT07279558 — Cannabidiol and Alcohol Use Disorder Phenotypes · Phase 2 · recruiting
NCT07056894 — Effects of Action-Based Cognitive Remediation on Substance Misuse in Early Phase Psychosis · NA · recruiting

Other Rutgers, The State University of New Jersey trials

Trials by the same sponsor.

NCT07243886 — Mobile-based Obstetric Monitoring for Pregnancies Complicated by Hypertension and/or Diabetes (MOM-HD) · NA · not yet recruiting
NCT06955130 — Lactate and Glycerol Contribution to Gluconeogenesis · NA · not yet recruiting
NCT06822010 — SeqUential GeMcitabine and MITomycin Treatment for Favorable High-Risk Upper Urinary Tract Urothelial Carcinoma · Phase 2 · not yet recruiting
NCT07525011 — Comparative Study of Denture Fabrication Techniques · NA · not yet recruiting
NCT06834204 — Advancing Care Coordination Between Cancer and Primary Care Teams for Complex Cancer Survivors · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03589274 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Rutgers, The State University of New Jersey
Last refreshed: 17 July 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03589274.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing